Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0MD6D
|
||||
Former ID |
DNC008098
|
||||
Drug Name |
9-benzyl-6-(benzylamino)-9H-purine-2-carbonitrile
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529240] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H16N6
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CNC2=NC(=NC3=C2N=CN3CC4=CC=CC=C4)C#N
|
||||
InChI |
1S/C20H16N6/c21-11-17-24-19(22-12-15-7-3-1-4-8-15)18-20(25-17)26(14-23-18)13-16-9-5-2-6-10-16/h1-10,14H,12-13H2,(H,22,24,25)
|
||||
InChIKey |
VVLPZPSTQWLQHU-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | Inhibitor | [529240] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.